Vaxcyte Inc (PCVX): PCVX -18% on VAX-24 delay reported last...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	829
Posts	119628
Boards Moderated	14
Alias Born	09/05/2002

DewDiligence

Re: None

Tuesday, 03/30/2021 12:17:04 PM

Tuesday, March 30, 2021 12:17:04 PM

PCVX -18% on VAX-24 delay reported last night (#msg-162862041).

I listened to PCVX’s CC last night and it’s clear that PCVX has a lot of work to do on the manufacturing front. PCVX is relying on Lonza for manufacturing the 24 conjugates that will comprise the VAX_24 pneumococcal vaccine, and some of these conjugates have yet to be produced. Moreover, the PCVX-Lonza relationship seems to be on the fritz insofar as PCVC executives jabbed at Lonza by implying that Lonza had moved slowly on PCVX tasks in order to serve other (higher-paying) clients.

I wouldn’t be surprised if the VAX-24 timeline slips further. VAX-24 is the kind of product candidate that belongs with a large drug/biotech company, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”